Co-enrichment of CD8-positive T cells and macrophages is associated with clinical benefit of tislelizumab in solid tumors.
Ye D, Desai J, Shi J, Liu SM, Shen W, Liu T, Shi Y, Wang D, Liang L, Yang S, Ma X, Jin W, Zhang P, Huang R, Shen Z, Zhang Y, Wu YL.
Ye D, et al. Among authors: shen w, shen z.
Biomark Res. 2023 Mar 7;11(1):25. doi: 10.1186/s40364-023-00465-w.
Biomark Res. 2023.
PMID: 36879284
Free PMC article.